Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2  (01-2009)

Period of time： 2009年2期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873|9|2

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2

Menu

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 113-131

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 132-144

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The AKT Axis as a Therapeutic Target in Autoimmune Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 145-150

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 151-177

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 178-186

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 187-198

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Inflammatory Bowel Disease and Celiac Disease: Overlaps in the Pathology and Genetics, and their Potential Drug Targets

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 9,issue 2 , Vol. 9, Iss. 2, 2009-06 , pp. 199-218

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 7 item(s)